
Zymergen Investor Relations Material
Latest events

Status Update
Zymergen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Zymergen Inc
Access all reports
Zymergen Inc. designs, develops, and commercializes microbes, molecules, and materials for research in the life sciences. It offers a solution that automates biology experiments; a suite of software tools for automation of plants and facilities; hardware components comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; automation control software; and integrated automation systems with parts and services. The company also provides reagent bottles and automated dispensing systems, as well as small molecule screening and process development platform comprising single cell engineered microorganisms with tool kits for analysis. In addition, it offers consulting and advisory services comprising process design to manufacturing services using its solutions for process development, strain engineering, microbial characterization, culture media development, fermentor vessel design and validation services.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ZY
Country
🇺🇸 United States